---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-22-000082"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2022-12-14T23:59:59+00:00"
generated_at: "2026-06-21T04:36:59.871875+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro adopts Fourth Amended and Restated Bylaws with universal proxy, enhanced disclosure rules

## Summary
- Board adopted amended bylaws effective Dec. 14, 2022, to comply with SEC universal proxy rules and recent Delaware law changes.
- Enhanced procedural mechanics and disclosure requirements for stockholder director nominations and proposals.
- Advance notice deadline for stockholder proposals and nominations at annual meetings has been changed.
- Updates include conforming edits and ministerial changes.

## SEC filing metadata
- accession: 0001285550-22-000082
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2022-12-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000082/0001285550-22-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000082/clpt-20221214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-22-000082
- JSON: https://secwatch.observer/filing/0001285550-22-000082.json
- Plain text: https://secwatch.observer/filing/0001285550-22-000082.txt

## Key facts
- Governance Changes
  ClearPoint Neuro, Inc.: Board adopted Fourth Amended and Restated Bylaws to enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals, including compliance with Rule 14a-19 and changes to advance notice deadlines (effective 2022-12-14).
  - Change: bylaw amendment
  - Effective: 2022-12-14
  source text: Effective as of December 14, 2022, the Board of Directors of ClearPoint Neuro, Inc. (the “Company”) adopted the Fourth Amended and Restated Bylaws in connection with the new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the General Corporation Law of the State of Delaware, and a periodic review of the bylaws.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000082/0001285550-22-000082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.